Results 41 to 50 of about 48,507 (298)

Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice

Arthritis Research & Therapy, 2012
IntroductionSoluble immune aggregates bearing intact Fc fragments are effective treatment for a variety of autoimmune disorders in mice. The better to understand the mechanisms by which Fc-bearing immune complexes suppress autoimmunity, and to develop a ...
Ajay Jain, H. Olsen, R. Vyzasatya, E. Burch, Yukimi Sakoda, E. Mérigeon, Ling Cai, Changwan Lu, M. Tan, K. Tamada, D. Schulze, David S. Block, S. Strome   +12 more
semanticscholar   +1 more source

Predictive Performance of Device‐Neonatal Skin Risk Assessment Scale to Evaluating Pressure Injuries Risk in the Neonates. An Observational Multicenter Study

Journal of Clinical Nursing, EarlyView.
ABSTRACT Aim To assess the validity of a modified Neonatal Skin Risk Assessment scale (Dev‐NSARS) for neonatal pressure injuries (PIs) in the neonatal intensive care unit (NICU) and neonatal sub‐intensive care unit (NICU‐Sub) environment. Background Medical devices are the leading cause of pressure injuries (PIs) in neonates, a key cause of morbidity ...
Biagio Nicolosi, Elisa Neri, Leonardo Fioravanti, Silvia Leoncini, Claudio De Felice, Pablo Garcìa‐Molina, Alessandra Mugnaini   +6 more
wiley   +1 more source

BMQ [PDF]

, 1963
BMQ: Boston Medical Quarterly was published from 1950-1966 by the Boston University School of Medicine and the Massachusetts Memorial ...
Antuna, Juan, Bagnoli, Thomas, Barber, Doris E., Cocchiarella, John P., Duke, Martin, Estes, J. Worth, Friedlander, Walter J., Goldsmith, Harry S., Gooding, Gretchen W., Goofman, Max L., Haseotes, Hytho V., Hass, Gerald, Hastings, A. Baird, Jackson, David R., Johnson, David S., Kechejian, Sarkis J., Kramer, Philip, Litman, George I., Madoff, Irving M., McLellan, Patricia A., O'Hara, Vincent S., Peabody, C. Newton, Pryles, Charles V., Small, Donald M., Tedeschi, Luke G., Walker, Sydney, III   +25 more
core  

Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. [PDF]

, 2008
Idiopathic thrombocytopenic purpura (ITP) is characterized by a low platelet count, which is the result of both increased pla- telet destruction and insufficient platelet production.
Amadori, S, Buccisano, F, Evangelista, M, Stasi, R, Stipa, E, Venditti, A   +5 more
core   +1 more source

Multiple splenic artery aneurysms in a patient with idiopathic thrombocytopenic purpura: A case report, brief literature review and discussion

Artery Research, 2010
Multiple splenic artery aneurysms in a patient with idiopathic thrombocytopenic purpura: A case report, brief literature review and discussion.
David Busel, Alonso Yanez, Edgard Jimenez, Christopher K. Johansen   +3 more
doaj   +1 more source

A prospective non‐inferiority trial of pathogen reduced platelets compared to non‐pathogen reduced platelets for correction of viscoelastic platelet function testing in cardiac surgery

Transfusion, Volume 65, Issue 7, Page 1293-1306, July 2025.
Abstract Background Cardiac surgery on cardiopulmonary bypass (CPB) may alter platelet (PLT) function causing bleeding. The goal of this study is to evaluate the hemostatic effect of PRT‐PLTs compared to untreated PLTs stored in platelet additive solution (PAS) following transfusion in bleeding patients undergoing cardiac surgery on CPB.
Magali J. Fontaine, Jackline J. M. Lasola, Aidaelis Martinez‐Hernandez, Juliana N. Marshall, Soren Bentzen, Min Zhan, Parvez M. Lokhandwala, Kenichi Tanaka, Carlos H. Villa, Alexis Jones, Chintamani D. Atreya, Reney A. Henderson   +11 more
wiley   +1 more source

Immunosuppressive and Non‐Immunosuppressive Drugs for Heart Xenotransplantation in Humans: Is Europe Ready?

Xenotransplantation, Volume 32, Issue 4, July/August 2025.
ABSTRACT Xenotransplantation is becoming an emerging field of interest for the treatment of end‐stage heart disease. In fact, the shortage of human heart donors in European countries requires the increasing investigation of alternative strategies such as heart xenotransplantation.
Nicola Pradegan, Annamaria Tolomeo, Diego Ciccarelli, Emanuele Cozzi, Antonio Vitiello, Andrea Zovi, Gino Gerosa   +6 more
wiley   +1 more source

Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura : A Single Technology Appraisal [PDF]

, 2008
Evidence Review Group (ERG) final report for the National Institute for Health and Clinical ExcellencePublisher ...
Boyers, Dwayne, Crowther, M, Fraser, Cynthia Mary, Jenkinson, David James, Jia, Xueli, Mowatt, Graham   +5 more
core  

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura

Haematologica, 2008
Rituximab 375 mg/m2 weekly for four weeks has significant activity in patients with immune thrombocytopenia. We evaluated the activity of lower dose rituximab (100 mg iv weekly for 4 weeks) in 28 adults with idiopathic thrombocytopenic purpura.
Francesco Zaja, Marta Lisa Battista, Maria Teresa Pirrotta, Salvatore Palmieri, Michela Montagna, Nicola Vianelli, Luciana Marin, Margherita Cavallin, Monica Bocchia, Marzia Defina, Micaela Ippoliti, Felicetto Ferrara, Francesca Patriarca, Maria Antonietta Avanzini, Mario Regazzi, Michele Baccarani, Miriam Isola, Franca Soldano, Renato Fanin   +18 more
doaj   +1 more source

Síndrome de Evans - presentación atípica de un linfoma raro

Galicia Clínica, 2022
Evans Syndrome is a rare autoimmune condition characterized by two or more cytopenias, usually autoimmune haemolytic anaemia and immune thrombocytopenic purpura. It can be primary/idiopathic or secondary to other diseases.
Catarina Teles Neto, Marta Valentim, Filipa Pedro, Pedro Luís, Ana Gameiro, Luís Siopa   +5 more
doaj   +1 more source